Is BioNTech More Than a One-Trick Pony?

·2-min read

BioNTech (NASDAQ: BNTX) is famous for its coronavirus vaccine, but the biotech has additional drug candidates in the works. In this video from Motley Fool Live, recorded on April 5, Fool.com Contributors Brian Orelli and Keith Speights discuss BioNTech's pipeline and what's in store for the company's future.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting